Last update:

Vitamin D analog shuts down pancreatic cancer's shield in a clinical trial

A small clinical trial led by Dana-Farber Cancer Institute researchers has put a Salk Institute idea to the test in patients: that activating the vitamin D receptor can help reshape the protective environment surrounding ...

Blocking two cancer pathways may curb medulloblastoma relapse, preclinical study suggests

For most children diagnosed with medulloblastoma, the most common malignant pediatric brain tumor, survival rates are encouraging. But for a subset, remission is not the end of the story. Roughly 30% of patients will see ...

Medical research news

Parkinson's symptoms trace to distinct brain circuits

Parkinson's disease is often treated as a single disorder. But for the more than 1.1 million people living with it in the United States, the disease can look different from one person to the next. Research from Carnegie Mellon ...

Blood test detects early signs of breast cancer recurrence

Researchers at Lund University have developed a blood test capable of detecting signs of breast cancer recurrence long before recurrence becomes visible on imaging or causes symptoms. It has previously been shown that this ...

Why do heights make your feet feel strange?

I wouldn't say that I'm afraid of heights. I can stand on a cliff path or look out from a tall building without the rush of panic people often associate with vertigo. What I really dislike is something much harder to explain: ...

Common asthma drug shows promise for reversing fatty liver

MUSC researchers are tackling MASH, or metabolic dysfunction-associated steatohepatitis, a liver disease affecting hundreds of millions worldwide. It is also a leading cause of liver transplantation, yet treatment options ...